BATON ROUGE, La., May 25, 2017 -- Amedisys Inc. (NASDAQ:AMED), one of the nation’s leading home health care, hospice and personal care companies, has received an average rating of 4.03 Stars – out of a possible 5 – for Quality of Patient Care across all of its home health centers from the Centers for Medicare & Medicaid Services (CMS). That figure represents a 15% increase from a year ago and above the industry average. Three-fourths of its home health centers (75%) achieved a rating of 4 Stars or better, compared to thirty percent (30%) last year.
“No metric better demonstrates our determination to deliver outstanding clinical results than ratings in home health from the all-important CMS Star program,” stated President and Chief Executive Officer Paul Kusserow. “And we’re making tremendous strides. We’ve now seen improvement for six straight quarters, and we’re on track for every one of the 330 home health care centers we operate in 34 states to achieve a quality Star rating of 4 or higher by the end of this year.”
Indeed, fifty-three of Amedisys’ home health care centers rated 4.5 Stars, with five attaining 5 Stars. Patient Satisfaction Star ratings have risen to 3.8, also above the industry average.
“Our care centers rank among the top in the nation for delivering quality patient care,” stated Chief Clinical Officer Susan Sender. “In fact, our July preview shows our quality of patient care Star ratings averaging 4.13, with 82% of our home health care centers at 4 Stars or higher. This is a direct result of our commitment to clinical distinction and investing in our people to provide the highest quality of care to our patients.”
According to CMS, its Home Health Compare website is designed to be a key tool for consumers to use for choosing a home health provider – an “easy-to-access, convenient source of authoritative information on provider quality.” In 2015, CMS added to its reporting system a one-to-five Star rating, to “summarize” 24 measures of provider performance such as “timely initiation of care” and “improvement in ambulation.”
About Amedisys
Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice and personal care. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based personal care; recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. More than 2,200 hospitals and 61,900 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, TN, Amedisys is a publicly held company. With approximately 16,000 employees, in 421 care centers in 34 states, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of more than 385,000 patients in need every year. For more information about the Company, please visit: www.amedisys.com.
Contact: Kendra Kimmons Managing Director of Communications 225-299-3708 [email protected]


Saks Global to End Saks on Amazon Partnership Amid Bankruptcy Restructuring
Pentagon and Anthropic Clash Over AI Safeguards in National Security Use
Panama Supreme Court Voids Hong Kong Firm’s Panama Canal Port Contracts Over Constitutional Violations
Meta Stock Surges After Q4 2025 Earnings Beat and Strong Q1 2026 Revenue Outlook Despite Higher Capex
Federal Judge Signals Possible Dismissal of xAI Lawsuit Against OpenAI
American Airlines Plans Return to Venezuela Flights After U.S. Lifts Ban
US Judge Rejects $2.36B Penalty Bid Against Google in Privacy Data Case
Elon Musk’s SpaceX Explores Merger Options With Tesla or xAI, Reports Say
Tesla Q4 Earnings Beat Expectations as Company Accelerates Shift Toward AI and Robotics
Toyota Retains Global Auto Sales Crown in 2025 With Record 11.3 Million Vehicles Sold
Apple Faces Margin Pressure as Memory Chip Prices Surge Amid AI Boom
Bob Iger Plans Early Exit as Disney Board Prepares CEO Succession Vote
Sandisk Stock Soars After Blowout Earnings and AI-Driven Outlook
Elon Musk’s Empire: SpaceX, Tesla, and xAI Merger Talks Spark Investor Debate
Panama Supreme Court Voids CK Hutchison Port Concessions, Raising Geopolitical and Trade Concerns
Chinalco and Rio Tinto Acquire Controlling Stake in Brazil’s CBA for $903 Million 



